JBIO
Price
$14.12
Change
-$0.23 (-1.60%)
Updated
Sep 29, 02:03 PM (EDT)
Capitalization
917.07M
48 days until earnings call
Intraday BUY SELL Signals
RYTM
Price
$96.39
Change
-$2.17 (-2.20%)
Updated
Sep 29, 03:32 PM (EDT)
Capitalization
6.79B
42 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

JBIO vs RYTM

JBIO vs RYTM Comparison Chart in %
View a ticker or compare two or three
VS
JBIO vs. RYTM commentary
Sep 29, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JBIO is a Buy and RYTM is a Buy.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
RYTM: Fundamental Ratings
RYTM
OUTLOOK RATING
1..100
15
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
PROFIT vs RISK RATING
1..100
20
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
56
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
JBIORYTM
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 7 days ago
83%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
N/A
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
Bearish Trend 7 days ago
88%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
74%
Advances
ODDS (%)
N/A
Bullish Trend 5 days ago
81%
Declines
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 15 days ago
73%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
89%
COMPARISON
Comparison
Sep 29, 2026
Stock price -- (JBIO: $14.35 vs. RYTM: $98.56)
Brand notoriety: JBIO and RYTM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: JBIO: 62% vs. RYTM: 107%
Market capitalization -- JBIO: $917.07M vs. RYTM: $6.79B
JBIO [@Biotechnology] is valued at $917.07M. RYTM’s [@Biotechnology] market capitalization is $6.79B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.37B. The average market capitalization across the [@Biotechnology] industry is $2.2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

JBIO’s FA Score shows that 1 FA rating(s) are green while RYTM’s FA Score has 1 green FA rating(s).

  • JBIO’s FA Score: 1 green, 4 red.
  • RYTM’s FA Score: 1 green, 4 red.
According to our system of comparison, both JBIO and RYTM are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

JBIO’s TA Score shows that 3 TA indicator(s) are bullish while RYTM’s TA Score has 4 bullish TA indicator(s).

  • JBIO’s TA Score: 3 bullish, 5 bearish.
  • RYTM’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, RYTM is a better buy in the short-term than JBIO.

Price Growth

JBIO (@Biotechnology) experienced а -14.28% price change this week, while RYTM (@Biotechnology) price change was -0.27% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.11%. For the same industry, the average monthly price growth was -7.79%, and the average quarterly price growth was +3.30%.

Reported Earning Dates

JBIO is expected to report earnings on Nov 16, 2026.

RYTM is expected to report earnings on Nov 10, 2026.

Industries' Descriptions

@Biotechnology (+0.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
JBIO
Daily Signal:
Gain/Loss:
RYTM
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BLZE13.540.35
+2.65%
Backblaze
BIIB228.691.09
+0.48%
Biogen
BSET18.18-0.10
-0.55%
Bassett Furniture Industries
KFY71.31-0.42
-0.59%
Korn Ferry
GLE0.49-0.01
-1.97%
Global Engine Group Holding Ltd